TELA Bio (TELA) EBITDA Margin (2018 - 2026)
TELA Bio (TELA) posted quarterly EBITDA Margin of 55.23% for Q1 2026, up 132.0% year-over-year from 23.81% in Q1 2025, and down 73.37% quarter-over-quarter from 31.86% in Q4 2025.
TELA Bio (TELA) EBITDA Margin (2018 - 2026) Analysis & Trends
TELA Bio's EBITDA Margin history runs 9 years deep, the most recent figure standing at 55.23% for Q1 2026.
- In Q1 2026, EBITDA Margin rose 132.0% year-over-year to 55.23%; the TTM figure through Mar 2026 stood at 41.84% (up 1400.0% YoY), while the FY2025 annual figure was 42.05%, up 718.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 55.23%, down from 31.86% in the prior quarter.
- The five-year high for EBITDA Margin was 29.07% in Q1 2024, with the low at 119.6% in Q1 2022.
- The 5-year median for EBITDA Margin is 67.64% (2023), against an average of 65.46%.
- The sharpest annual moves came in 2024 and 2025: EBITDA Margin jumped 6543 bps in 2024, then slumped 2748 bps in 2025.
- TELA Bio's EBITDA Margin stood at 81.22% in 2022, then grew by 11 bps to 72.23% in 2023, then jumped by 34 bps to 47.33% in 2024, then jumped by 33 bps to 31.86% in 2025, then plunged by 73 bps to 55.23% in 2026.
- Business Quant data shows TELA's EBITDA Margin at 55.23% in Q1 2026, 31.86% in Q4 2025, and 36.51% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 19.15% |
| 10 | TELA Bio | 36.34 Mn | 5.92 Mn | 13.94 Mn | -48.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -48.12% |
| Mar 31, 2026 | -55.23% |
| Dec 31, 2025 | -31.86% |
| Sep 30, 2025 | -36.51% |
| Jun 30, 2025 | -44.96% |
| Mar 31, 2025 | -56.54% |
| Dec 31, 2024 | -47.33% |
| Sep 30, 2024 | -49.40% |
| Jun 30, 2024 | -71.90% |
| Mar 31, 2024 | -29.07% |
| Dec 31, 2023 | -72.23% |
| Sep 30, 2023 | -67.64% |
| Jun 30, 2023 | -71.49% |
| Mar 31, 2023 | -94.50% |
| Dec 31, 2022 | -81.22% |
| Sep 30, 2022 | -85.02% |
| Jun 30, 2022 | -98.38% |
| Mar 31, 2022 | -119.60% |
| Dec 31, 2021 | -91.40% |
| Sep 30, 2021 | -94.29% |